UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trace Amines and Their Receptors

Pharmacological reviews, 2018-07, Vol.70 (3), p.549-620

2018

Volltextzugriff (PDF)

Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges

Pharmacology & therapeutics (Oxford), 2017-12, Vol.180, p.161-180

2017

Volltextzugriff (PDF)

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

European neuropsychopharmacology, 2016-08, Vol.26 (8), p.1327-1337

2016

Volltextzugriff (PDF)

Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones

European neuropsychopharmacology, 2015-03, Vol.25 (3), p.365-376

2015

Volltextzugriff (PDF)

Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome

British journal of pharmacology, 2018-02, Vol.175 (3), p.532-543

2018

Volltextzugriff (PDF)

Pharmacological profile of novel psychoactive benzofurans

British journal of pharmacology, 2015-07, Vol.172 (13), p.3412-3425

2015

Volltextzugriff (PDF)

Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats

The Journal of neuroscience, 2018-02, Vol.38 (8), p.1959-1972

2018

Volltextzugriff (PDF)

Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)

Neuropharmacology, 2015-12, Vol.99, p.546-553

2015

Volltextzugriff (PDF)

Wakefulness Induced by TAAR1 Partial Agonism in Mice Is Mediated Through Dopaminergic Neurotransmission

International journal of molecular sciences, 2024-11, Vol.25 (21), p.11351

2024

Volltextzugriff (PDF)

Pharmacological profile of mephedrone analogs and related new psychoactive substances

Neuropharmacology, 2018-05, Vol.134 (Pt A), p.4-12

2018

Volltextzugriff (PDF)

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study

PloS one, 2012-05, Vol.7 (5), p.e36476

2012

Volltextzugriff (PDF)

Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)

Neuropharmacology, 2018-05, Vol.134 (Pt A), p.141-148

2018

Volltextzugriff (PDF)

Structure‐activity Relation of Halogenated 2,5‐Dimethoxyamphetamines Compared to their α‑Desmethyl (2C) Analogues

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Monoamine Receptor and Transporter Interaction Profiles of 4‐Alkyl‐Substituted 2,5‐Dimethoxyamphetamines

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems

European journal of pharmacology, 2018-01, Vol.819, p.242-247

2018

Volltextzugriff (PDF)

The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative

International journal of molecular sciences, 2021-08, Vol.22 (15), p.8277

2021

Volltextzugriff (PDF)

Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats

Molecular psychiatry, 2022-12, Vol.27 (12), p.4861-4868

2022

Volltextzugriff (PDF)

In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1

The Journal of pharmacology and experimental therapeutics, 2016-04, Vol.357 (1), p.134-144

2016

Volltextzugriff (PDF)

Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use

Biochemical pharmacology, 2019-06, Vol.164, p.129-138

2019

Volltextzugriff (PDF)

Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds

Progress in neuro-psychopharmacology & biological psychiatry, 2015-12, Vol.63, p.70-75

2015

Volltextzugriff (PDF)

Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics

Biological psychiatry (1969), 2017-11, Vol.82 (9), p.623-633

2017

Volltextzugriff (PDF)

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Proceedings of the National Academy of Sciences - PNAS, 2011-05, Vol.108 (20), p.8485-8490

2011

Volltextzugriff (PDF)

Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D2 Receptor Controls Cocaine’s Neurochemical Actions

Scientific reports, 2017-10, Vol.7 (1), p.1-12, Article 13901

2017

Volltextzugriff (PDF)

Pharmacological profiles of compounds in preworkout supplements (“boosters”)

European journal of pharmacology, 2019-09, Vol.859, p.172515, Article 172515

2019

Volltextzugriff (PDF)

The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats

Neuropsychopharmacology (New York, N.Y.), 2017-06, Vol.42 (7), p.1458-1470

2017

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(108)
Buchkapitel
(2)

Sprache

Englisch
(110)

Erscheinungsjahr

n.n

Thema

Science & Technology
(82)
Life Sciences & Biomedicine
(77)
Animals
(54)
Pharmacology & Pharmacy
(48)
Neurosciences
(40)
Humans
(39)
Neurosciences & Neurology
(37)
Mice
(27)
Dopamine
(23)
Male
(20)
Hek293 Cells
(19)
Psychiatry
(19)
Rats
(18)
Receptors, G-Protein-Coupled - Metabolism
(18)
Receptors, G-Protein-Coupled - Agonists
(16)
Serotonin
(14)
Female
(12)
Pharmacology
(11)
Amphetamines
(10)
Biochemistry & Molecular Biology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Trace Amines and Their Receptors

Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones

Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome

Pharmacological profile of novel psychoactive benzofurans

Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats

Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)

Wakefulness Induced by TAAR1 Partial Agonism in Mice Is Mediated Through Dopaminergic Neurotransmission

Pharmacological profile of mephedrone analogs and related new psychoactive substances

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study

Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)

Structure‐activity Relation of Halogenated 2,5‐Dimethoxyamphetamines Compared to their α‑Desmethyl (2C) Analogues

Monoamine Receptor and Transporter Interaction Profiles of 4‐Alkyl‐Substituted 2,5‐Dimethoxyamphetamines

Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems

The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative

Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats

In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1

Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use

Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds

Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D2 Receptor Controls Cocaine’s Neurochemical Actions

Pharmacological profiles of compounds in preworkout supplements (“boosters”)

The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats

Suchergebnisse filtern